The Staufen1-dependent cell cycle regulon or how a misregulated RNA-binding protein leads to cancer

Florence Bonnet-Magnaval1, Luc DesGroseillers1

  • 1Département de biochimie et médecine moléculaire, Faculté de médecine, Université de Montréal, 2900 Édouard Montpetit, Montréal, QC, H3T 1J4, Canada.

Insights

The RNA-binding protein Staufen1 (STAU1) regulates cell division and differentiation. Its misregulation in cancer promotes cell proliferation and tumor development, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Biology

Background:

  • Staufen1 (STAU1) is an RNA-binding protein implicated in controlling cellular decisions.
  • In normal cells, STAU1 maintains a balance in gene expression crucial for differentiation and cell division.
  • Dysregulation of STAU1 disrupts this balance, promoting cancer development.

Purpose of the Study:

  • To investigate the role of Staufen1 (STAU1) in cell proliferation and cancer development.
  • To understand how STAU1 misregulation contributes to the tumorigenic equilibrium.
  • To explore STAU1 as a potential target for cancer therapy.

Main Methods:

  • Analysis of STAU1's role in post-transcriptional regulation of RNA targets.
  • Examination of STAU1-mediated gene regulation in cancer cells.
  • Study of the STAU1-dependent cell cycle regulon.

Main Results:

  • STAU1 misregulation leads to altered expression of cell cycle regulators, favoring proliferation.
  • Cancer cells exhibit a tumorigenic equilibrium influenced by STAU1.
  • Increased STAU1 expression can promote apoptosis, suggesting a dual role.

Conclusions:

  • STAU1 plays a critical role in maintaining cellular homeostasis and its dysregulation is a key factor in cancer initiation.
  • The STAU1-dependent cell cycle regulon serves as a model for understanding RNA-binding protein-driven oncogenesis.
  • Targeting STAU1 may offer a strategy to combat cancer by restoring apoptotic pathways.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.0K